BIOME DIAGNOSTICS

Founded in 2018, Biome Diagnostics GmbH is an Austria-based MedTech company dedicated to advancing precision medicine in the area of cancer detection and treatment through breakthrough microbiome-based technologies. The company is strategically positioned at the intersection of state-of-the-art DNA sequencing and advanced machine learning algorithms to develop best-in-class biomarkers for routine clinical diagnostics. Biome Diagnostics is the world's first microbiome company to be ISO 13485 and ... ISO 9001 certified and has launched the novel CE-IVD marked microbiome diagnostic „BiomeOne®“ in May 2022. With a high accuracy, BiomeOne® predicts response and immune-related adverse events of cancer immunotherapy for multiple cancer types. Biome Diagnostics has collected more than 20,000 samples of healthy and cancer patient.More